Key Takeaways Expanding surgeon network, label extensions, and rising regenerative therapy demand are fueling market penetration, revenue growth, and long-term diversification opportunities. Operational improvements and strong payer acceptance are supporting margin expansion, increased profitability, and stable long-term financial performance.